D265-0138 Screening compound: N-(4-{[1,1'-biphenyl]-4-yl}-1,3-thiazol-2-yl)-2,4-dimethyl-1,3-thiazole-5-carboxamide

D265-0138 Screening compound: N-(4-{[1,1'-biphenyl]-4-yl}-1,3-thiazol-2-yl)-2,4-dimethyl-1,3-thiazole-5-carboxamide
D265-0138 Screening compound: N-(4-{[1,1'-biphenyl]-4-yl}-1,3-thiazol-2-yl)-2,4-dimethyl-1,3-thiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D265-0138
N-(4-{[1,1'-biphenyl]-4-yl}-1,3-thiazol-2-yl)-2,4-dimethyl-1,3-thiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D265-0138

Molecular Formula

C21H17N3OS2 (C21 H17 N3 OS2)

Compound Name

N-(4-{[1,1'-biphenyl]-4-yl}-1,3-thiazol-2-yl)-2,4-dimethyl-1,3-thiazole-5-carboxamide

IUPAC name

N-(4-{[11'-biphenyl]-4-yl}-13-thiazol-2-yl)-24-dimethyl-13-thiazole-5-carboxamide

SMILES

Cc1c(C(Nc2nc(-c(cc3)ccc3-c3ccccc3)cs2)=O)sc(C)n1

InChI

InChI=1S/C21H17N3OS2/c1-13-19(27-14(2)22-13)20(25)24-21-23-18(12-26-21)17-10-8-16(9-11-17)15-6-4-3-5-7-15/h3-12H,1-2H3,(H,23,24,25)

InChI Key

FCBLNPMGHQSFPO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD08568192

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

391.52

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.078

Distribution Coefficient, logD

6.078

Water Solubility, LogSw

-5.78

Polar Surface Area

43.222

Acid Dissociation Constant (pKa)

10.12

Base Dissociation Constant (pKb)

1.35

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.50

D265-0138 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with D265-0138 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D265-0138?
Check Price and Availability of D265-0138, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D265-0138 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D265-0138
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D265-0138
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D265-0138 available by request